abstract |
(57) [Summary] The present invention provides at least one selected from inosine, guanosine-n'-monophosphate (GMP) (n '= 2', 3'or 5 '), uridine and thymidine. MRS characterized by containing nucleic acid constituents as active ingredients A preventive and therapeutic agent for infectious disease is provided. [Effect] The preventive and therapeutic agent for MRSA infection of the present invention is useful as a novel preventive and therapeutic agent for MRSA infection. |